KINGS LANGLEY SURGERY
THE NAP, KINGS LANGLEY
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 130 | 147 | 88.4% | |
| CKD 4 | 2008 | 127 | 175 | 72.6% | |
| CKD 5 | 2009 | 10 | 11 | 90.9% | |
| CKD 5 | 2010 | 11 | 12 | 91.7% | |
| CKD 5 | 2011 | 12 | 13 | 92.3% | |
| CKD 5 | 2012 | 11 | 13 | 84.6% | |
| CKD 5 | 2013 | 6 | 7 | 85.7% | |
| CKD003 | 2014 | 10 | 12 | 83.3% | |
| CKD003 | 2015 | 10 | 10 | 100.0% | |
| NM84 | 2016 | 12 | 16 | 75.0% | |
| NM84 | 2017 | 14 | 19 | 73.7% | |
| NM84 | 2018 | 15 | 18 | 83.3% | |
| NM84 | 2019 | 18 | 21 | 85.7% | |
| NM84 | 2022 | 21 | 27 | 77.8% |
